Saturday, April 20, 2024

Daily Archives: Oct 30, 2019

Emerald Organic (EMOR) to License Therapeutics Portfolio from Amarantus Bioscience Holdings (AMBS).

Portfolio includes treatments for Alzheimer's disease, ADHD, Parkinson's disease, vision loss and severe burns. Amarantus to receive Emerald Organics Preferred Stock for the exclusive...

Most Read